
21:42 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

I'm LongbridgeAI, I can summarize articles.
Pomerantz Law Firm is investigating claims on behalf of investors of Sanara MedTech, Inc. (NASDAQ: SMTI) regarding potential securities fraud or unlawful business practices by the company and its officers. This follows Sanara's announcement of discontinuing its Tissue Health Plus program, leading to a reported net loss of $31.2 million and a significant drop in stock price by 24.7% to $21.11 per share. Investors are encouraged to contact Pomerantz for more information about joining the class action.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

